Glutamine regulates the human epithelial intestinal HCT-8 cell proteome under apoptotic conditions.
Glutamine plays a key role in the metabolism of rapidly dividing cells, including enterocytes and lymphocytes, which may contribute to its beneficial clinical effects. Gut mucosal homeostasis is achieved through a balance between cell proliferation and apoptosis. In T cells, glutamine up-regulates antiapoptotic proteins and down-regulates proapoptotic proteins. In gut mucosa, glutamine prevents apoptosis in rat epithelial cell lines, whereas glutamine starvation induces apoptosis through caspase activation. Finally glutamine specifically prevents tumor necrosis factor-alpha-related apoptosis in the human intestinal cell line HT-29. Comparative functional proteomics enables the characterization of each differentially expressed protein in intestinal cells in response to modifications of nutritional environment. The influence of glutamine on intestinal proteome expression in apoptotic conditions has not been studied and evaluated. This comparative proteomics study was performed in the human epithelial intestinal cell line HCT-8 under experimental apoptotic conditions to investigate the influence of glutamine on protein expression during apoptosis. The pharmaconutritional effects of glutamine were determined under 2 mm (physiological concentration) and 10 mm (pharmaconutritional concentration) conditions. About 1,800 protein spots were revealed in both conditions. Comparative assessments indicated that 28 proteins were differentially expressed significantly (i.e. at least 2-fold modulated and Student's t test with p </= 0.05) in response to an increase of glutamine concentration in the culture medium. Twenty-four proteins were identified by mass spectrometry and associated databases. From these proteins, 34% are involved in cell cycle and apoptosis mechanisms, 17% are involved in signal transduction, and 13% are involved in cytoskeleton organization. These data were integrated in a proposed schema of the interactome under apoptotic conditions. In conclusion, this study provides the first holistic picture of proteome modulation by glutamine in a human enterocytic cell line under apoptotic conditions and supports further evaluation of nutritional modulation of human intestinal proteome in various pathological conditions where apoptosis may be involved.
Deniel
Nicolas
N
Groupe Aden EA3234, Université de Rouen, IFRMP23, 22 boulevard Gambetta, 76183 Rouen cedex 1, France.
Marion-Letellier
Rachel
R
Charlionet
Roland
R
Tron
François
F
Leprince
Jérôme
J
Vaudry
Hubert
H
Ducrotté
Philippe
P
Déchelotte
Pierre
P
Thébault
Sandrine
S
D017209:Apoptosis / Q000187:drug effects*; D002457:Cell Extracts; D045744:Cell Line, Tumor; D015180:Electrophoresis, Gel, Two-Dimensional; D020895:Enterocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D005973:Glutamine / Q000494:pharmacology*; D006801:Humans; D015151:Immunoblotting; D009363:Neoplasm Proteins / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D020543:Proteome / Q000378:metabolism*
D002457:Cell Extracts; D009363:Neoplasm Proteins; D020543:Proteome; D005973:Glutamine